|
RVMDW Revolution Medicines Inc 1628171 |
| Income Statement |
|
Net Income
|
2026-03-31
|
$-453,816,000.00 |
| Balance Sheet |
|
Current Assets
|
$1,967,913,000.00 |
|
Assets
|
$2,253,737,000.00 |
|
Current Liabilities
|
$289,599,000.00 |
|
Liabilities
|
$753,820,000.00 |
|
Equity
|
$1,499,917,000.00 |
|
Shares Out
|
200178626.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-354,165,000.00 |
|
Investing Cash Flow
|
$172,615,000.00 |
| Market Analysis |
Market Cap
|
$1,977,764,824.88 |
|
Price
|
$9.05 |
|
BVPS
|
7.49 |
|
PB
|
1.32 |
|
EPS
|
-2.29 |
|
FCF
|
$-355,703,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-08-01 09:31:56 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-08-03 10:01:59 |
|
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view RVMDW documents filed with the SEC.
RVMDW Filings
Clear
